GB9810544D0 - Novel angiogenesis inhibitors - Google Patents

Novel angiogenesis inhibitors

Info

Publication number
GB9810544D0
GB9810544D0 GBGB9810544.8A GB9810544A GB9810544D0 GB 9810544 D0 GB9810544 D0 GB 9810544D0 GB 9810544 A GB9810544 A GB 9810544A GB 9810544 D0 GB9810544 D0 GB 9810544D0
Authority
GB
United Kingdom
Prior art keywords
angiogenesis inhibitors
novel angiogenesis
novel
inhibitors
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810544.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GBGB9810544.8A priority Critical patent/GB9810544D0/en
Publication of GB9810544D0 publication Critical patent/GB9810544D0/en
Priority to CA002303830A priority patent/CA2303830A1/en
Priority to EP98948427A priority patent/EP1017682A4/en
Priority to PCT/US1998/019789 priority patent/WO1999016755A1/en
Priority to AU95003/98A priority patent/AU744939B2/en
Priority to JP2000513841A priority patent/JP2001518470A/en
Ceased legal-status Critical Current

Links

GBGB9810544.8A 1997-09-26 1998-05-15 Novel angiogenesis inhibitors Ceased GB9810544D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9810544.8A GB9810544D0 (en) 1998-05-15 1998-05-15 Novel angiogenesis inhibitors
CA002303830A CA2303830A1 (en) 1997-09-26 1998-09-22 Novel angiogenesis inhibitors
EP98948427A EP1017682A4 (en) 1997-09-26 1998-09-22 Novel angiogenesis inhibitors
PCT/US1998/019789 WO1999016755A1 (en) 1997-09-26 1998-09-22 Novel angiogenesis inhibitors
AU95003/98A AU744939B2 (en) 1997-09-26 1998-09-22 Novel angiogenesis inhibitors
JP2000513841A JP2001518470A (en) 1997-09-26 1998-09-22 Novel angiogenesis inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810544.8A GB9810544D0 (en) 1998-05-15 1998-05-15 Novel angiogenesis inhibitors

Publications (1)

Publication Number Publication Date
GB9810544D0 true GB9810544D0 (en) 1998-07-15

Family

ID=10832188

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9810544.8A Ceased GB9810544D0 (en) 1997-09-26 1998-05-15 Novel angiogenesis inhibitors

Country Status (1)

Country Link
GB (1) GB9810544D0 (en)

Similar Documents

Publication Publication Date Title
EP1109555A4 (en) Novel angiogenesis inhibitors
EP1097147A4 (en) Novel angiogenesis inhibitors
EP0984692A4 (en) Novel angiogenesis inhibitors
EP1017682A4 (en) Novel angiogenesis inhibitors
GB9900416D0 (en) Inhibitors
PL341642A1 (en) Novel macrolydes
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
HUP0202076A3 (en) Triazine angiogenesis inhibitors
EP1068213A4 (en) Novel aminoorganofunctionalsiloxanes
PL345574A1 (en) Angiogenesis inhibitors
HK1042695A1 (en) Prothease inhibitors
GB9821993D0 (en) Centraliser
GB9816729D0 (en) Substituted cyclohexylaminopyrimidines
HK1039937A1 (en) Substituted 3-thiocarbamoylpyrazoles
PL347397A1 (en) Substituted 3-aryl-pyrazoles
GB2389113B (en) B-secretase inhibitor
EP1025851A4 (en) Alpha-glucosidase inhibitor
PL345866A1 (en) Substituted cyclooctadepsipeptides
HK1039335A1 (en) Substituted benzoylcyclohexandiones
GB9810544D0 (en) Novel angiogenesis inhibitors
GB9800681D0 (en) Novel angiogenesis inhibitors
GB9822700D0 (en) Novel angiogenesis inhibitors
EP1354589A4 (en) Angiogenesis inhibitors
GB9826992D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)